Siam Pharmaceutical Co., Ltd.

Overview

Siam Pharmaceutical Co., Ltd. is a leading privately-held pharmaceutical company in Thailand, committed to the development, production, and distribution of health products. The company specializes in a diverse range of therapeutic areas, providing quality pharmaceutical products to enhance healthcare outcomes.

Therapeutic areas

API / Drug Master Files

Siam Pharmaceutical Co., Ltd. holds 18 active (20 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• SEMAGLUTIDEActive2025-06-06
• AMPICILLIN TRIHYDRATE (POWDER)Active2023-03-30
• AMOXICILLIN TRIHYDRATE (COMPACTED POWDER)Active2022-02-13
• AMOXICILLIN TRIHYDRATE (POWDER)Active2021-12-23
• CEFUROXIME AXETILActive2021-08-17
• CEFTRIAXONE SODIUM (NON-STERILE BULK) USPActive2019-02-28
• DEACYL CEFTRIAXONE (7-ACT)Active2018-06-12
• AMOXICILLIN TRIHYDRATE, USPActive2018-05-15
• IDEBENONE (NON-STERILE)Active2017-08-28
• NILOTINIB HYDROCHLORIDE MONOHYDRATEActive2017-04-14
• DEACETYL-7-AMINOCEPHALOSPORANIC ACID (D-7-ACA)Active2017-03-08
• 6-AMINOPENICILLANIC ACIDActive2016-08-02
• 7-AMINOCEPHALOSPORANIC ACIDActive2016-05-09
• CLAVULANATE POTASSIUM DILUTED 1:1 WITH MICROCRYSTALLINE CELLULOSEActive2014-03-18
• CLAVULANATE POTASSIUM DILUTED 1:1 WITH SILICON DIOXIDEActive2014-03-12

Showing 15 of 20 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Siam Pharmaceutical Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.